Dapper-1 induces myocardial remodeling through activation of canonical wnt signaling in cardiomyocytes

Hypertension

Volumn 61, Issue 6, 2013, Pages 1177-1183

  Hagenmueller, Marco ^a   Riffel, Johannes H ^a   Bernhold, Elmar ^a   Fan, Jingjing ^a   Zhang, Min ^a   Ochs, Marco ^a   Steinbeisser, Herbert ^a   Katus, Hugo A ^b   Hardt, Stefan E ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

cardiac remodeling, ventricular; transgenic mice; Wnt signaling pathway

Indexed keywords

BETA CATENIN; DISHEVELLED 2; DPR1 PROTEIN; PHENYLEPHRINE; PROTEIN; UNCLASSIFIED DRUG; WNT3A PROTEIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HYPERTROPHY; MARKER GENE; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE; WNT SIGNALING PATHWAY;

CARDIAC REMODELING, VENTRICULAR; TRANSGENIC MICE; WNT SIGNALING PATHWAY;

ANIMALS; CARDIOMEGALY; DISEASE MODELS, ANIMAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RNA, MESSENGER; UP-REGULATION; VENTRICULAR REMODELING; WNT SIGNALING PATHWAY;

EID: 84878944974     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.00391     Document Type: Article

References (19)

1. Orenes-Piñero E, Hernández-Romero D, Jover E, de la Morena G, Valdés M, Marín F. An insight of novel pharmacological therapies in hypertrophic cardiomyopathy. Med Chem. 2011; 7: 275-285.
2. Eisenberg CA, Eisenberg LM. WNT11 promotes cardiac tissue formation of early mesoderm. Dev Dyn. 1999; 216: 45-58. (Pubitemid 29416172)
3. Marvin MJ, Di Rocco G, Gardiner A, Bush SM, Lassar AB. Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev. 2001; 15: 316-327. (Pubitemid 32155147)
4. Pandur P, Läsche M, Eisenberg LM, Kühl M. Wnt-11 activation of a noncanonical Wnt signalling pathway is required for cardiogenesis. Nature. 2002; 418: 636-641.
5. Tzahor E, Lassar AB. Wnt signals from the neural tube block ectopic cardiogenesis. Genes Dev. 2001; 15: 255-260. (Pubitemid 32155141)
6. Malekar P, Hagenmueller M, Anyanwu A, Buss S, Streit MR, Weiss CS, Wolf D, Riffel J, Bauer A, Katus HA, Hardt SE. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. Hypertension. 2010; 55: 939-945.
7. Lee YN, Gao Y, Wang HY. Differential mediation of the Wnt canonical pathway by mammalian Dishevelleds-1,-2, and-3. Cell Signal. 2008; 20: 443-452.
8. van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H. Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem. 2002; 277: 17901-17905. (Pubitemid 34967600)
9. Chen X, Shevtsov SP, Hsich E, Cui L, Haq S, Aronovitz M, Kerkelä R, Molkentin JD, Liao R, Salomon RN, Patten R, Force T. The beta-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophy. Mol Cell Biol. 2006; 26: 4462-4473. (Pubitemid 43877567)
10. Hagenmueller M, Malekar P, Fieger C, Weiss CS, Buss SJ, Wolf D, Katus HA, Hardt SE. Depletion of mammalian target of rapamycin (mTOR) via siRNA mediated knockdown leads to stabilization of beta-catenin and elicits distinct features of cardiomyocyte hypertrophy. FEBS Lett. 2010; 584: 74-80.
11. Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, Walters B, Woodgett J, Kilter H, Force T. Stabilization of beta-catenin by a Wntindependent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci USA. 2003; 100: 4610-4615. (Pubitemid 36457778)
12. Rezvani M, Liew CC. Role of the adenomatous polyposis coli gene product in human cardiac development and disease. J Biol Chem. 2000; 275: 18470-18475. (Pubitemid 30414806)
13. Hirschy A, Croquelois A, Perriard E, Schoenauer R, Agarkova I, Hoerstrup SP, Taketo MM, Pedrazzini T, Perriard JC, Ehler E. Stabilised beta-catenin in postnatal ventricular myocardium leads to dilated cardiomyopathy and premature death. Basic Res Cardiol. 2010; 105: 597-608.
14. Baurand A, Zelarayan L, Betney R, Gehrke C, Dunger S, Noack C, Busjahn A, Huelsken J, Taketo MM, Birchmeier W, Dietz R, Bergmann MW. Beta-catenin downregulation is required for adaptive cardiac remodeling. Circ Res. 2007; 100: 1353-1362. (Pubitemid 46742926)
15. Cheyette BN, Waxman JS, Miller JR, Takemaru K, Sheldahl LC, Khlebtsova N, Fox EP, Earnest T, Moon RT. Dapper, a Dishevelledassociated antagonist of beta-catenin and JNK signaling, is required for notochord formation. Dev Cell. 2002; 2: 449-461. (Pubitemid 34436574)
16. Gloy J, Hikasa H, Sokol SY. Frodo interacts with Dishevelled to transduce Wnt signals. Nat Cell Biol. 2002; 4: 351-357. (Pubitemid 34521030)
17. Yau TO, Chan CY, Chan KL, Lee MF, Wong CM, Fan ST, Ng IO. HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing. Oncogene. 2005; 24: 1607-1614. (Pubitemid 40396090)
18. Yuan G, Wang C, Ma C, Chen N, Tian Q, Zhang T, Fu W. Oncogenic function of DACT1 in colon cancer through the regulation of ?-catenin. PLoS ONE. 2012; 7: e34004.
19. Zhang L, Gao X, Wen J, Ning Y, Chen YG. Dapper 1 antagonizes Wnt signaling by promoting dishevelled degradation. J Biol Chem. 2006; 281: 8607-8612. (Pubitemid 43847964)